Latest News

Date Title Topic
24 Nov 2014 Immuno-Oncology 2014 Press Release: High-Dose Interleukin-2 Effective in mRCC Pre-Treated With VEGF-Targeted Therapies Genitourinary cancers - Immuno-oncology
Webcasts
21 Nov 2014 Immuno-Oncology 2014 Press Release: Immune Checkpoint Inhibitors May Work in Brain Cancer Central nervous system malignancies - Immuno-oncology
21 Nov 2014 Immuno-Oncology 2014 Press Release: Possibilities for Personalised Vaccines Revealed at ESMO Symposium Personalised medicine - Immuno-oncology
20 Nov 2014 Immuno-Oncology 2014 Press Release: Immunotherapy Set to Revolutionise Cancer Treatment Immuno-oncology
20 Nov 2014 Patients with Advanced Papillary RCC Respond Well to a Combination of Bevacizumab and Erlotinib Genitourinary cancers - Anticancer agents & Biologic therapy
Follicular Lymphoma
17 Nov 2014 FDA Approves Bevacizumab in Combination with Chemotherapy for Platinum Resistant, Recurrent Ovarian Cancer Gynaecologic malignancies - Anticancer agents & Biologic therapy
Programme
14 Nov 2014 Ten Years of Progress in Translational Research in Oncology Translational research
14 Nov 2014 13º Congresso Nacional de Oncologia
12 Nov 2014 Lung Cancer Screening with Low-Dose CT Could Be Cost Effective Bioethics, legal and economic issues - Epidemiology/Etiology/Cancer Prevention - Lung and other thoracic tumours
10 Nov 2014 ESMO Press Release: ESMO Announces Annual Medical Oncology Congress Platform in Europe from 2016
07 Nov 2014 Olaparib in Patients with BRCA-Related Cancers Cancer in Special Situations - Anticancer agents & Biologic therapy